Form D · Biotechnology
Inflammasome Therapeutics, Inc.
Newton, MA · CIK 0001989925
Offering snapshot reported May 4, 2026 · SEC filing
- Reported sold
- $13.2M Offering amount: $13.2M
- Investors reported
- 62 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2026 | Initial | $13,155,645 | No comparison | 62 | SEC filing |
| Mar 17, 2025 | Initial | $2,450,172 | No comparison | 27 | SEC filing |
| Jan 26, 2024 | Amendment | $3,796,600 | $1,000,000vs Aug 14, 2023 | 24 | SEC filing |
| Aug 14, 2023 | Initial | $2,796,600 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-582798
Source: Form D, filed May 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Balamurali K. Ambati | Director, Executive |
| Jayakrishna Ambati | Director, Executive |
| Paul Ashton | Director, Executive |
| Napoleone Ferrara | Director |
| Babur B. Lateef | Director |
| Joon Lee | Director |
| Chaniyilparampu N. Ramchand | Director |
| Mary Weber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
57 Chapel St. Ste. 100
Newton, MA, 02458
Newton, MA, 02458